≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Oral leukoplakia and related diseases

Endpoint Browser PheWeb

K11_ORAL_LEUCOPLAC_RELAT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K13.2
  • Cause of death: ICD-10 — K13.2

2 out of 7 registries used, show all original rules.

2037

4. Check minimum number of events

None

2037

5. Include endpoints

None

2037

6. Filter based on genotype QC (FinnGen only)

2037

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11356 6396 4921
Only index persons 10736 6104 4632
Unadjusted period prevalence (%)
Whole population 0.16 0.18 0.14
Only index persons 0.20 0.22 0.18
Median age at first event (years)
Whole population 59.45 60.72 57.82
Only index persons 59.14 60.32 57.57

-FinnGen-

Key figures

All Female Male
Number of individuals 2037 1161 876
Unadjusted period prevalence (%) 0.39 0.40 0.39
Median age at first event (years) 59.80 59.06 60.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1842
Matched controls
18420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K13.20
ICD-10 Finland
Idiopathic leukoplakia
533.9
323.0
450
11
K13.29
ICD-10 Finland
Indefinite leukoplakia
1249.4
323.0
1052
19
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
68.3
323.0
600
129
EKA10
NOMESCO Finland
Biopsy of cheek
37.6
313.7
405
137
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
289.7
272.7
272
11
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
15.3
203.3
352
280
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
11.8
194.0
382
401
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
2075.7
186.6
178
*
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
855.7
162.2
157
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
16.0
148.6
250
179
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
131.0
136.3
145
12
SAA03
NOMESCO Finland
Extended examination of mouth
3.4
129.9
978
4611
L43.8
ICD-10 Finland
Other lichen planus
18.8
129.7
204
121
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
96.1
129.2
142
16
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
7.9
121.0
296
434
A07AA02
ATC
nystatin; oral
6.5
120.5
343
625
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
120.3
903
4169
ECA20
NOMESCO Finland
Biopsy of gingiva
27.0
116.7
163
66
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
18.6
111.7
176
104
SXA10
NOMESCO Finland
Epithel biopsy of mouth
23.1
111.4
163
77
SBA00
NOMESCO Finland
Microbiological examinations
12.5
106.7
199
177
K13.78
ICD-10 Finland
Other change in the oral mucosa
12.2
90.6
170
152
L43.9
ICD-10 Finland
Lichen planus, unspecified
13.5
87.8
157
126
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
105.1
82.7
90
9
SXC03
NOMESCO Finland
Other oral or dental procedure
19.9
74.5
114
61
SAA04
NOMESCO Finland
Special inverstigation of mouth
5.5
73.7
234
473
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.7
73.4
667
3197
TEA00
NOMESCO Finland
Biopsy of lip
23.7
68.7
99
44
EHA10
NOMESCO Finland
Biopsy of palate
19.6
62.0
95
51
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
88.3
61.3
68
8
A01AB09
ATC
miconazole; local oral
3.6
59.2
298
935
Z2221
NOMESCO Finland
Medical doctor
2.4
54.9
629
3303
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.6
48.1
101
111
B37.08
ICD-10 Finland
Other candidal stomatitis
16.1
46.5
76
49
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
26.5
46.1
64
25
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
60.6
45.5
53
9
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.6
44.4
214
641
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
153.6
43.0
45
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
21.7
42.9
63
30
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
41.8
189
535
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
16.6
41.0
66
41
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
40.2
910
6159
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
406.1
40.2
40
*
EKB00
NOMESCO Finland
Excision of lesion of cheek
27.8
39.6
54
20
D20
ICPC
Mouth/tongue/lip symptom/complaint
4.5
38.7
145
345
SAA02
NOMESCO Finland
Basic examination of mouth
1.9
38.2
1155
8622
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
38.0
797
5207
J02AC01
ATC
fluconazole; systemic
1.9
37.7
776
5033
EJB40
NOMESCO Finland
Hemiglossectomy
71.4
37.1
42
6
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
193.9
36.9
38
*
A01AC01
ATC
triamcinolone; local oral
6.4
36.8
100
164
L43.0
ICD-10 Finland
Hypertrophic lichen planus
17.8
36.4
57
33
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
36.3
285
1186
SBB10
NOMESCO Finland
Teeth copy
3.8
34.7
157
444
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.3
34.2
72
80
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
33.9
1256
9841
WX110
NOMESCO Finland
Local anesthesy
1.9
33.6
1256
9857
A01AB04
ATC
amphotericin B; local oral
3.5
33.2
163
493
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
332.8
33.0
33
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.2
33.0
70
79
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.9
32.7
110
234
EB1WA
NOMESCO Finland
NA
14.5
32.5
55
39
Z3226
NOMESCO Finland
Physiotherapist
2.2
32.5
413
2181
GBB00
NOMESCO Finland
Tracheostomy
8.6
32.3
71
85
D07AD01
ATC
clobetasol; topical
2.2
32.2
362
1807
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
73.5
31.9
36
5
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
9.6
31.5
65
70
D07AC01
ATC
betamethasone; topical
1.9
31.1
684
4451
R4110
NOMESCO Finland
Physiotherapy
1.9
29.8
551
3360
EDB00
NOMESCO Finland
Partial excision of mandible
37.7
29.4
37
10
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.1
28.7
165
561
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
28.3
757
5205
K05.31
ICD-10 Finland
Periodontitis pronounced
2.5
27.1
236
1031
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
98.2
26.7
29
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
26.2
585
3776
K12.18
ICD-10 Finland
Other forms of stomatitis
12.3
26.1
47
39
K13.24
ICD-10 Finland
Gum problems in smokers
94.8
25.7
28
*
Z2446
NOMESCO Finland
Social worker
3.1
25.4
145
489
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
24.5
200
842
WX002
NOMESCO Finland
Sedation and analgesia
1.9
24.2
420
2473
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
23.1
23.9
34
15
J01DB01
ATC
cefalexin; oral
1.8
23.7
1472
12680
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
126.6
23.6
25
*
EJ2S1
NOMESCO Finland
Photography of oral mucosa
28.6
23.2
31
11
Z3231
NOMESCO Finland
Registered nurse
1.8
22.7
527
3413
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
3.3
22.3
119
383
K12.10
ICD-10 Finland
Stomatitis NOS
14.5
22.1
37
26
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
11.3
21.9
41
37
EAA10
NOMESCO Finland
Excision of lesion of lip
7.1
21.7
53
76
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
222.5
21.6
22
*
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
116.4
21.6
23
*
ZXA05
NOMESCO Finland
Left side
1.7
21.6
522
3413
K14.61
ICD-10 Finland
Glossodynia
9.2
21.6
45
50
ZXE00
NOMESCO Finland
One hour or less
1.6
21.5
717
5140
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
21.4
514
3351
EBA10
NOMESCO Finland
Surgical removal of tooth
2.4
20.9
195
879
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
20.8
643
4500
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
8.5
20.7
45
54
ZXC10
NOMESCO Finland
Use of laser
4.5
20.5
74
171
EMAK
NOMESCO Finland
NA
3.5
20.1
97
290
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
20.0
387
2350
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
19.8
312
1759
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
40.5
19.5
24
6
K13.6
ICD-10 Finland
Irritative hyperplasia of oral mucosa
7.5
19.5
46
63
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
19.5
212
1028
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
19.1
183
834
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
19.0
328
1910
K13.23
ICD-10 Finland
Leukokeratosis nicotina palati
+∞
18.8
18
*
K14.9
ICD-10 Finland
Disease of tongue, unspecified
21.1
18.6
27
13
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
101.1
18.6
20
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
18.6
325
1900
SDA02
NOMESCO Finland
Parodonthologic therapy
1.6
18.5
560
3867
N02AX02
ATC
tramadol; systemic, rectal
1.6
18.5
773
5803
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
10.8
17.9
34
32
R13
ICD-10 Finland
Dysphagia
2.5
17.5
145
614
K02.1
ICD-10 Finland
Caries of dentine
1.5
16.9
923
7320
L43.3
ICD-10 Finland
Subacute (active) lichen planus
19.5
16.9
25
13
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.0
16.7
96
327
K12.00
ICD-10 Finland
Recurrent oral aphthae
5.9
16.7
46
79
ECA30
NOMESCO Finland
Excision of lesion of gingiva
5.8
16.7
47
83
N05AH04
ATC
quetiapine; oral
1.9
16.6
271
1543
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
90.9
16.6
18
*
XQ802
NOMESCO Finland
Epicutan test
3.1
16.5
94
317
A02BC02
ATC
pantoprazole; systemic
1.5
16.3
1178
9909
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
12.9
16.2
28
22
SXC05
NOMESCO Finland
Other oral or dental procedure
2.7
16.0
110
419
K11.70
ICD-10 Finland
Hypoptyalism
9.6
15.9
32
34
N03AX16
ATC
pregabalin; oral
1.6
15.9
437
2922
Z01.2
ICD-10 Finland
Dental examination
1.5
15.9
678
5064
K05.30
ICD-10 Finland
Periodontitis complex
1.9
15.8
236
1301
EEB00
NOMESCO Finland
Partial excision of maxilla
60.5
15.8
18
*
J01FF01
ATC
clindamycin; systemic
1.6
15.6
482
3319
ZXA00
NOMESCO Finland
Right side
1.6
15.6
514
3602
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
15.6
936
7524
K13.03
ICD-10 Finland
Keilit UNS
19.4
15.6
23
12
EBB10
NOMESCO Finland
Insertion of dental implant
5.2
15.5
48
95
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
38.4
15.4
19
5
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
15.4
657
4893
EBA00
NOMESCO Finland
Extraction of tooth
1.6
15.4
550
3929
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
12.5
14.9
26
21
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
5.3
14.9
45
87
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
14.7
381
2498
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
5.8
14.7
41
72
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
14.7
464
3208
N02AA05
ATC
oxycodone; systemic
1.8
14.6
278
1664
ZXE90
NOMESCO Finland
More than 22 hours
8.5
14.5
31
37
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
15.5
14.4
23
15
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
14.3
343
2197
E0000UV
ATC
NA
1.5
14.3
660
4986
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.5
14.2
110
451
H02AB06
ATC
prednisolone; systemic
1.5
14.1
817
6468
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
14.5
14.1
23
16
L43
ICD-10 Finland
Lichen planus
5.8
13.9
39
69
XF612
NOMESCO Finland
Measurement of central venous pressure
17.7
13.8
21
12
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
13.8
483
3414
L43.1
ICD-10 Finland
Bullous lichen planus
24.0
13.8
19
8
EHB00
NOMESCO Finland
Excision of lesion of palate
20.2
13.8
20
10
130
Kela drug reimbursment
Malignant tumour
2.1
13.6
166
842
8070/3-C06.9
ICD-O-3
Squamous cell carcinoma, NOS, of mouth, NOS
+∞
13.6
13
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.0
13.5
77
261
SPF30
NOMESCO Finland
Soling for prothesis
3.9
13.4
55
145
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
13.4
619
4657
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.6
13.3
397
2695
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.2
13.2
144
698
UJF32
NOMESCO Finland
Coloscopy
1.5
13.2
473
3359
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
13.1
1139
9722
A02BC05
ATC
esomeprazole; systemic
1.5
13.0
722
5636
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
12.9
397
2710
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
12.8
860
6967
N02BE01
ATC
paracetamol; systemic, rectal
1.6
12.6
1539
14040
RD210
NOMESCO Finland
NA
4.7
12.6
42
91
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
12.5
248
1500
RS316
NOMESCO Finland
NA
13.3
12.4
21
16
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
12.4
64
204
J01MA02
ATC
ciprofloxacin; systemic
1.5
12.3
678
5266
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
4.5
12.3
42
94
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.5
12.2
56
163
R03AC02
ATC
salbutamol; inhalant
1.4
12.1
867
7075
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.7
12.1
34
61
D07AB08
ATC
desonide; topical
1.9
12.0
184
1020
SPF20
NOMESCO Finland
Temporary soling for filling
5.8
11.9
33
58
EBB15
NOMESCO Finland
Insertion of dental implant abutment
5.8
11.9
33
58
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.3
11.9
43
102
N06AX21
ATC
duloxetine; oral
1.9
11.8
184
1025
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
11.8
104
456
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
11.8
93
386
K13.1
ICD-10 Finland
Cheek and lip biting
9.0
11.7
24
27
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
9.7
11.7
23
24
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
2.9
11.7
72
256
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
7.4
11.7
27
37
R06AE07
ATC
cetirizine; oral
1.4
11.7
700
5512
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
11.6
115
533
R01AD09
ATC
mometasone; nasal
1.4
11.5
716
5671
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
10.1
11.5
22
22
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
11.5
11
*
M25.5
ICD-10 Finland
Pain in joint
1.5
11.5
467
3397
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
11.5
87
354
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
120.7
11.4
12
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.1
11.4
61
200
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
11.4
398
2800
S01.50
ICD-10 Finland
Open wound in oral cavity
5.6
11.3
32
58
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
35.2
11.3
14
*
H02AB07
ATC
prednisone; oral
1.7
11.2
259
1634
N07BA03
ATC
varenicline; oral
2.4
11.2
94
401
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
11.2
215
1286
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
25.2
11.1
15
6
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
20.2
11.1
16
8
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
11.0
571
4360
WZA90
NOMESCO Finland
Other doctors statement
1.5
11.0
376
2629
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
10.9
776
6282
L43.2
ICD-10 Finland
Lichenoid drug reaction
43.6
10.9
13
*
SBA10
NOMESCO Finland
Measurement of excretion of saliva
5.1
10.9
33
65
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.9
10.9
26
38
J01CA04
ATC
amoxicillin; systemic
1.4
10.8
1358
12168
XQ800
NOMESCO Finland
Prick test
2.1
10.8
124
612
A02BA02
ATC
ranitidine; systemic
1.5
10.8
358
2481
N05BA01
ATC
diazepam; systemic, rectal
1.7
10.8
239
1489
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
10.7
254
1614
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
10.7
777
6310
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
60.3
10.6
12
*
S29
ICPC
Skin symptom/complaint other
1.6
10.6
292
1930
ZXD05
NOMESCO Finland
Urgent procedure
1.5
10.6
496
3707
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
6.0
10.6
28
47
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
10.5
196
1158
N06AX11
ATC
mirtazapine; oral
1.4
10.5
526
3981
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
10.4
398
2847
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
10.3
401
2878
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
10.3
81
337
EJB60
NOMESCO Finland
Partial excision of floor of mouth
32.7
10.3
13
*
A02BC01
ATC
omeprazole; systemic
1.5
10.3
481
3585
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
10.3
173
988
EEA10
NOMESCO Finland
Biopsy of maxilla
23.5
10.2
14
6
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
10.2
369
2603
L04AD01
ATC
ciclosporin; systemic
3.9
10.2
40
103
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
10.1
73
290
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.6
10.1
73
291
J01FA06
ATC
roxithromycin; oral
1.4
10.1
692
5545
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
10.1
107
512
J01DA01
ATC
[U] cefalexin; systemic
1.4
10.1
1061
9147
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
11.3
10.1
18
16
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
10.0
123
628
N05BA04
ATC
oxazepam; oral
1.5
10.0
416
3027
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
40.3
10.0
12
*
WX872
NOMESCO Finland
Intensive care
2.2
9.9
99
461
K07.60
ICD-10 Finland
Snapping jaw
2.4
9.8
80
339
WX290
NOMESCO Finland
Other blockade of nerve
1.4
9.8
628
4965
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
8.2
9.8
21
26
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
8.2
9.8
21
26
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.7
9.8
66
251
N05CD07
ATC
temazepam; oral
1.7
9.8
233
1479
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.1
9.8
106
514
L04AA06
ATC
mycophenolic acid; systemic
3.9
9.8
39
102
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
9.8
176
1030
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
20.1
9.8
14
7
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
9.7
70
278
N05CF01
ATC
zopiclone; oral
1.4
9.7
562
4358
A01AB10
ATC
natamycin; local oral
2.7
9.7
63
236
ECB20
NOMESCO Finland
Oral alveoplasty
4.6
9.7
32
70
H02AB04
ATC
methylprednisolone; systemic
1.6
9.7
256
1673
L28
ICPC
Limited function/disability (L)
1.6
9.7
284
1909
SPA02
NOMESCO Finland
Preparation for dental prosthetics
3.2
9.7
49
156
K08.3
ICD-10 Finland
Retained dental root
2.0
9.6
122
634
P01BA02
ATC
hydroxychloroquine; oral
1.9
9.5
146
811
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
9.5
103
500
EAA30
NOMESCO Finland
Partial excision of lower lip
21.8
9.3
13
6
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
9.3
662
5320
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
9.3
601
4748
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
9.3
1527
14121
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
10.7
9.3
17
16
E000006
ATC
NA
1.9
9.3
131
704
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
9.3
894
7550
A06AD11
ATC
lactulose; oral
1.6
9.2
251
1652
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
9.2
97
466
UJH02
NOMESCO Finland
Anoscopy
2.4
9.2
78
336
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
9.1
271
1826
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
9.1
806
6707
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
9.1
105
522
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.2
9.1
45
141
WX892
NOMESCO Finland
Monitored bed care
1.9
9.1
136
749
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
9.1
70
290
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
9.1
69
283
R51.80
ICD-10 Finland
Headache
1.6
9.0
221
1418
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.6
9.0
65
259
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
9.0
714
5836
127
Kela drug reimbursment
Transplant complication
4.0
8.9
34
86
L28.0
ICD-10 Finland
Lichen simplex chronicus
4.4
8.9
31
72
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
8.9
196
1222
R01AD08
ATC
fluticasone; nasal
1.4
8.9
444
3341
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.9
8.9
128
695
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
8.9
154
893
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.1
8.9
33
82
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.4
8.8
76
331
E000001
ATC
NA
1.5
8.8
323
2282
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
8.8
189
1169
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.8
309
2162
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
8.8
98
481
N03AX12
ATC
gabapentin; oral
1.6
8.7
266
1804
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
8.7
145
829
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.6
8.6
28
61
R07.0
ICD-10 Finland
Pain in throat
2.1
8.6
101
506
D07XC01
ATC
betamethasone, combinations; topical
1.6
8.6
201
1274
J37.0
ICD-10 Finland
Chronic laryngitis
2.5
8.5
63
255
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.0
8.5
105
538
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
8.5
94
461
M79.6
ICD-10 Finland
Pain in limb
1.4
8.5
594
4741
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
8.5
121
655
K13.09
ICD-10 Finland
Disease of the lips UNS
27.6
8.5
11
*
R4190
NOMESCO Finland
Nutritional therapy
2.6
8.4
58
225
8070/3-C03.0
ICD-O-3
Squamous cell carcinoma, NOS, of upper Gum
90.5
8.4
9
*
K11.2
ICD-10 Finland
Sialoadenitis
2.5
8.4
64
261
D19
ICPC
Teeth/gum symptom/complaint
1.4
8.4
390
2893
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
8.4
104
534
UJC01
NOMESCO Finland
Scopy of lower throat
4.5
8.4
28
63
EJC30
NOMESCO Finland
Reconstruction of tongue
+∞
8.3
8
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
8.3
301
2118
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
8.3
212
1373
J01FA10
ATC
azithromycin; systemic
1.3
8.3
899
7678
D83
ICPC
Mouth/tongue/lip disease
7.1
8.2
19
27
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.7
8.2
34
93
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.2
640
5196
S21
ICPC
Skin texture symptom/complaint
1.6
8.2
203
1306
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
8.2
299
2111
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
8.1
455
3492
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
2.8
8.1
49
177
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.5
8.1
59
236
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.1
118
646
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
4.5
8.1
27
61
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
8.0
110
589
K14.09
ICD-10 Finland
Glossit UNS
22.1
8.0
11
5
EKA00
NOMESCO Finland
Incision of cheek
22.1
8.0
11
5
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.0
8.0
43
145
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.9
408
3077
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
7.9
161
979
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.9
174
1082
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.9
706
5841
A01
ICPC
Pain general/multiple sites
1.8
7.9
137
795
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
3.0
7.9
42
140
J01AA02
ATC
doxycycline; systemic
1.4
7.9
1347
12280
L17
ICPC
Foot/toe symptom/complaint
1.4
7.8
416
3159
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.8
627
5106
ZY010
NOMESCO Finland
Hospital outpatient
2.4
7.8
66
286
C05.0
ICD-10 Finland
Malignant neoplasm: Hard palate
45.2
7.7
9
*
J01MA14
ATC
moxifloxacin; systemic
1.7
7.7
147
877
J01DA06
ATC
[U] cefuroxime; systemic
1.6
7.7
231
1559
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
7.7
138
808
K03.66
ICD-10 Finland
Tooth plaque
1.9
7.7
105
562
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
7.7
83
403
D07AC13
ATC
mometasone; topical
1.4
7.6
463
3599
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
7.6
121
681
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
25.1
7.6
10
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
25.1
7.6
10
*
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
4.0
7.6
28
70
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
7.6
384
2889
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
6.2
7.5
19
31
K14.60
ICD-10 Finland
Glossopyrosis
6.2
7.5
19
31
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
5.4
7.5
21
39
KMAK
NOMESCO Finland
NA
1.3
7.5
782
6606
R68.2
ICD-10 Finland
Dry mouth, unspecified
4.7
7.5
24
52
N06AB04
ATC
citalopram; systemic
1.4
7.5
356
2647
L04AX01
ATC
azathioprine; systemic
2.2
7.4
72
333
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.4
264
1851
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
7.4
374
2810
ZXA10
NOMESCO Finland
Bilateral
1.4
7.4
320
2334
B01AB05
ATC
enoxaparin; parenteral
1.4
7.4
519
4129
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.7
7.3
152
930
G44.2
ICD-10 Finland
Tension-type headache
1.6
7.3
193
1262
ZX120
NOMESCO Finland
Intravenous
1.7
7.3
155
955
H53.1
ICD-10 Finland
Subjective visual disturbances
1.9
7.3
104
565
EDB20
NOMESCO Finland
Hemimandibulectomy
+∞
7.3
7
*
C06.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of other and unspecified parts of mouth
+∞
7.3
7
*
C00.4
ICD-10 Finland
Malignant neoplasm: Lower lip, inner aspect
+∞
7.3
7
*
C09.1
ICD-10 Finland
Malignant neoplasm: Tonsillar pillar (anterior)(posterior)
+∞
7.3
7
*
C06.21
ICD-10 Finland
Malignant tumor of the lower retromolar surface
+∞
7.3
7
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
9.4
7.3
14
15
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
9.4
7.3
14
15
R01AD11
ATC
triamcinolone; nasal
1.7
7.2
143
865
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.4
7.2
33
99
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.2
7.2
69
320
Z72.0
ICD-10 Finland
Tobacco use
2.8
7.2
44
161
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
7.2
164
1031
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
7.2
281
2007
R53
ICD-10 Finland
Malaise and fatigue
1.4
7.2
314
2292
C07AB07
ATC
bisoprolol; oral
1.3
7.2
813
6935
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
7.2
105
576
ZXD20
NOMESCO Finland
Day surgery
1.6
7.2
206
1372
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.2
352
2628
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.7
7.2
29
79
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
5.0
7.1
21
42
ECB00
NOMESCO Finland
Suture of gingiva
2.3
7.1
60
263
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
7.1
100
540
N06AX16
ATC
venlafaxine; oral
1.6
7.1
196
1298
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
7.0
75
365
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
8.8
7.0
14
16
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.5
7.0
50
200
GD6AD
NOMESCO Finland
CT of chest and neck
10.1
7.0
13
13
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.4
7.0
57
245
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
7.0
107
595
A04
ICPC
Weakness/tiredness general
1.6
7.0
201
1343
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
7.0
163
1033
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.8
6.9
41
147
K06.23
ICD-10 Finland
Irritative hyperplasia of edentulous ridge [denture hyperplasia]
6.3
6.9
17
27
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
6.9
206
1387
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
13.8
6.9
11
8
L50.8
ICD-10 Finland
Other urticaria
3.3
6.9
32
98
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.7
6.9
131
785
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.7
6.8
126
747
R03BB04
ATC
tiotropium bromide; inhalant
1.6
6.8
168
1079
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
6.8
202
1356
Z43.1
ICD-10 Finland
Attention to gastrostomy
11.0
6.8
12
11
K01.0
ICD-10 Finland
Embedded teeth
3.9
6.8
26
68
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
6.8
226
1562
TJD20
NOMESCO Finland
Change of gastrostomy tube
7.2
6.7
15
21
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
6.7
146
908
J05AB11
ATC
valaciclovir; oral
1.5
6.7
202
1363
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
6.7
83
430
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
6.7
311
2300
C08CA01
ATC
amlodipine; oral
1.3
6.7
608
5017
ZX114
NOMESCO Finland
Intramuscular
3.3
6.7
31
95
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
6.7
110
630
R02
ICPC
Shortness of breath/dyspnoea
1.6
6.7
193
1290
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
6.6
111
637
K13.00
ICD-10 Finland
Cheilitis NOS
5.9
6.6
17
29
L12
ICPC
Hand/finger symptom/complaint
1.5
6.6
211
1445
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
6.6
369
2820
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.5
283
2061
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
6.5
342
2583
H03AA01
ATC
levothyroxine sodium; systemic
1.4
6.5
383
2953
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
2.5
6.5
46
184
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.8
6.5
25
66
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.5
360
2745
K13.70
ICD-10 Finland
Melanin pigmentation in the mouth
70.1
6.4
7
*
K13.3
ICD-10 Finland
Hairy leukoplakia
70.1
6.4
7
*
EJB50
NOMESCO Finland
Total glossectomy
70.1
6.4
7
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
6.4
174
1143
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
4.7
6.4
20
43
L03
ICPC
Low back symptom/complaint
1.4
6.4
364
2786
B37.0
ICD-10 Finland
Candidal stomatitis
3.5
6.4
27
77
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
6.4
193
1305
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
6.3
394
3059
A46
ICD-10 Finland
Erysipelas
1.5
6.3
229
1608
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
6.3
167
1092
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
6.0
6.3
16
27
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
11.1
6.3
11
10
J01MA12
ATC
levofloxacin; systemic
1.4
6.3
307
2286
C03CA01
ATC
furosemide; systemic
1.3
6.3
479
3843
R4120
NOMESCO Finland
Occupational therapy
1.8
6.3
101
573
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.5
6.3
45
182
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
6.3
6
*
K13.02
ICD-10 Finland
Cheilitis angular
+∞
6.3
6
*
C03.9
ICD-10 Finland
Malignant neoplasm: Gum, unspecified
+∞
6.3
6
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.4
6.2
48
201
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.2
6.2
59
273
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
26.8
6.2
8
*
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
26.8
6.2
8
*
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
26.8
6.2
8
*
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
26.8
6.2
8
*
D07AA02
ATC
hydrocortisone; topical
1.5
6.2
194
1320
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.1
6.2
22
54
R52.9
ICD-10 Finland
Pain, unspecified
1.6
6.2
141
888
SPA01
NOMESCO Finland
Pre-prosthetic dental procedures
6.3
6.2
15
24
SFA00
NOMESCO Finland
Small filling
1.5
6.1
197
1350
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.8
6.1
96
543
J01FA01
ATC
erythromycin; systemic
1.5
6.1
194
1329
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.7
6.1
37
137
ZZA00
NOMESCO Finland
Split skin graft
2.2
6.1
55
249
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
6.1
63
305
SDA10
NOMESCO Finland
Parodonthologic therapy of advnaced and complicated changes of alveolar bone
4.4
6.0
20
46
SPE01
NOMESCO Finland
Mucosa-supported partial denture
3.0
6.0
31
103
A02BC03
ATC
lansoprazole; oral
1.3
6.0
477
3847
WX199
NOMESCO Finland
Other local analgesia
2.3
6.0
50
219
N06AB03
ATC
fluoxetine; oral
1.5
6.0
190
1295

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
174
218
8.63
131.15
2.1
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
458
2018
2.64
65.77
1.8
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1056
6915
2.09
57.31
2.8
2.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
56
66
8.70
43.95
4.7
2.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
345
1709
2.23
36.26
2.2
2.2
g/l
0.2
0.2
0.31
333
1593
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1112
8264
1.76
33.55
7.4
6.1
mmol/l
1.2
1.2
1.34
1019
7472
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1026
7495
1.74
32.49
2.2
2.0
pmol/l
96.0
94.8
0.32
536
3798
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1616
13522
1.94
31.82
9.3
7.7
u/l
81.5
78.7
1.25
1527
12723
(3006315) Basophils [#/volume] in Blood
1123
8525
1.71
29.97
7.4
5.7
e9/l
0.0
0.0
0.52
961
7290
(42870588) Differential panel, method unspecified - Blood
839
5909
1.71
29.38
7.1
5.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1114
8493
1.69
28.76
7.5
5.7
e9/l
0.6
0.6
0.04
954
7249
(3024561) Albumin [Mass/volume] in Serum or Plasma
1042
7824
1.68
28.35
5.1
4.8
g/l
35.2
35.2
0.00
982
7263
(3013115) Eosinophils [#/volume] in Blood
1143
8813
1.68
27.92
7.8
5.9
e9/l
0.2
0.2
0.35
996
7660
(3019198) Lymphocytes [#/volume] in Blood
1127
8696
1.66
27.11
7.5
5.7
e9/l
1.8
1.9
1.42
984
7592
(3007853) Bacteria identified in Skin by Aerobe culture
357
1983
1.97
27.06
2.0
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1189
9310
1.67
26.93
7.0
6.3
umol/l
11.9
11.6
0.20
1134
8832
(40758558) Short blood count panel - Blood
650
4355
1.72
26.71
8.9
6.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1056
8041
1.65
26.52
7.4
5.8
%
58.2
57.5
1.15
981
7489
(3002030) Lymphocytes/100 leukocytes in Blood
1067
8178
1.64
25.85
7.6
6.0
%
26.5
27.4
1.92
987
7587
(3019069) Monocytes/100 leukocytes in Blood
1049
8007
1.64
25.83
7.9
6.2
%
8.8
8.8
0.03
977
7462
(3013707) Erythrocyte sedimentation rate by Westergren method
1520
12769
1.75
25.81
5.1
4.2
mm/h
13.8
13.2
0.81
1401
11777
(3013650) Neutrophils [#/volume] in Blood by Automated count
1248
9962
1.65
25.60
10.7
9.0
e9/l
4.2
4.1
0.15
1078
8656
(3033658) Prothrombin time (PT) actual/Normal
659
4475
1.70
25.54
5.1
3.9
%
88.9
89.2
0.11
648
4369
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
635
4298
1.69
24.76
2.5
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1152
9060
1.62
24.66
8.1
6.9
mmol/l
1.2
1.2
3.29
1010
7632
(3006504) Eosinophils/100 leukocytes in Blood
1039
7977
1.62
24.48
7.5
5.9
%
2.9
2.9
0.14
964
7404
(3022096) Basophils/100 leukocytes in Blood
1016
7768
1.61
24.27
7.5
5.9
%
0.7
0.7
0.58
942
7224
(3015377) Calcium [Moles/volume] in Serum or Plasma
830
6170
1.58
21.45
3.6
3.5
mmol/l
2.4
2.4
0.20
713
5369
(3012095) Magnesium [Moles/volume] in Serum or Plasma
460
2955
1.72
21.25
4.3
3.3
mmol/l
0.8
0.8
1.51
432
2747
(3052851) Hemolysis interference index of Serum or Plasma
131
534
2.55
21.06
3.7
3.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
395
2441
1.77
20.90
6.4
5.7
mmol/l
1.0
1.0
0.74
376
2252
(3044640) Blood type and Crossmatch panel - Blood
760
5595
1.57
20.14
2.7
2.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
288
1641
1.88
19.81
6.4
7.5
mmol/l
8.4
10.3
5.00
272
1562
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
518
3527
1.63
18.84
4.9
3.9
ng/l
588.4
388.5
0.23
435
2859
(3021960) Folate [Moles/volume] in Serum or Plasma
607
4316
1.58
18.34
1.6
1.6
nmol/l
19.3
20.8
1.88
541
3642
(3013826) Glucose [Moles/volume] in Serum or Plasma
1249
10376
1.53
18.31
6.1
4.9
mmol/l
6.8
6.8
0.02
1193
9759
(3031040) Bacteria [#/volume] in Urine by Automated count
1345
11354
1.54
18.30
5.6
4.7
e6/l
774.3
2087.1
0.76
12
181
(3023368) Bacteria identified in Blood by Culture
681
4982
1.55
18.09
4.9
4.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
738
5526
1.53
17.48
2.4
2.2
u/l
182.7
213.9
0.69
702
5170
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1720
15477
1.72
17.06
5.7
4.9
mu/l
1.9
2.0
0.80
1571
14050
(4010399)
225
1240
1.92
17.04
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
317
1953
1.74
16.66
3.2
2.6
umol/l
9.9
8.3
0.40
262
1708
(3018418) pH of Serum or Plasma
723
5438
1.51
16.55
5.2
4.1
ph
7.4
7.4
0.86
85
1045
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
725
5457
1.51
16.53
3.6
3.2
u/l
40.7
35.5
0.29
691
5167
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
232
1305
1.88
16.49
1.8
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
276
1647
1.78
16.18
3.0
2.3
u/l
42.1
41.0
0.04
220
1410
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1269
10715
1.49
16.14
3.6
3.2
u/l
56.4
52.2
0.69
1164
9904
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1832
16854
1.86
15.95
21.4
15.3
mg/l
24.7
24.8
0.03
1566
13461
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
445
3040
1.59
15.57
3.1
2.8
e6/l
0.9
1.3
1.23
259
1754
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
912
7255
1.47
15.48
2.6
2.3
nmol/l
76.4
78.6
1.55
817
6440
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
288
1763
1.74
15.41
2.1
1.8
%
1.7
1.5
2.87
248
1510
(3037467) Urinalysis macro (dipstick) panel - Urine
1369
11789
1.49
15.38
5.3
4.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
416
2822
1.60
14.93
3.3
3.0
e6/l
2.6
2.5
0.07
226
1548
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
94
389
2.48
14.68
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
94
389
2.48
14.68
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
441
3052
1.57
14.47
1.5
1.5
g/l
2.6
2.5
0.28
251
1808
(3032080) INR in Blood by Coagulation assay
921
7410
1.44
14.36
7.3
10.0
inr
1.2
1.3
1.75
172
2060
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1466
12889
1.49
14.12
4.6
4.1
pmol/l
14.9
14.9
0.00
1330
11652
(36304419) Bacteria [Presence] in Urine
633
4758
1.48
14.01
3.9
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
379
2556
1.59
13.84
2.2
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
480
3433
1.52
13.45
1.3
1.2
u/ml
1.4
1.5
0.03
109
908
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
177
981
1.88
13.12
8.7
9.9
mmol/l
24.6
24.4
0.53
166
921
(3019550) Sodium [Moles/volume] in Serum or Plasma
1885
17668
1.90
13.05
24.0
18.0
mmol/l
139.3
139.7
5.82
1847
17228
(3030467) Casts [#/volume] in Urine by Automated count
642
4897
1.45
12.97
3.9
3.2
e6/l
0.4
0.5
0.87
489
3707
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
985
8134
1.41
12.72
4.1
4.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
424
2985
1.53
12.70
2.1
1.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
322
2139
1.60
12.43
8.0
7.7
kpa
5.2
5.1
0.88
311
2042
(3027801) Oxygen [Partial pressure] in Arterial blood
322
2139
1.60
12.43
8.0
7.7
kpa
12.2
12.2
0.03
312
2043
(3003396) Base excess in Arterial blood by calculation
322
2140
1.60
12.41
8.0
7.7
mmol/l
1.3
1.1
0.31
258
1673
(3023103) Potassium [Moles/volume] in Serum or Plasma
1885
17709
1.86
12.35
24.2
18.1
mmol/l
4.0
4.0
0.31
1845
17243
(3001122) Ferritin [Mass/volume] in Serum or Plasma
853
6903
1.41
12.22
3.0
2.8
ug/l
132.8
143.6
0.66
783
6321
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
105
3.67
12.06
2.3
2.1
e6/l
961.6
705.1
0.73
15
43
(3048689) Calprotectin [Mass/mass] in Stool
283
1835
1.63
12.05
2.2
2.2
ug/g
140.1
150.2
0.14
232
1456
(3011397) Hemoglobin [Presence] in Urine by Test strip
539
4023
1.46
12.04
3.9
3.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
478
3490
1.48
11.93
1.7
1.8
nmol/l
1098.2
1189.6
1.19
368
2623
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
585
4448
1.44
11.81
2.3
2.2
mg/l
2.9
3.1
0.60
508
3764
(3051611) Lipemic interference index of Serum or Plasma
55
196
2.86
11.58
3.5
3.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
414
5607
0.67
11.48
2.8
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
323
2186
1.57
11.46
1.5
1.3
titre
518.3
534.7
0.06
71
473
(3018095) Leukocytes [#/volume] in Urine
769
6174
1.39
11.29
4.5
3.8
e6/l
53.7
115.8
2.64
552
4422
(3021879) Hepatitis B virus core Ab [Presence] in Serum
172
993
1.80
11.18
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
240
1528
1.65
10.95
1.8
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
602
4663
1.41
10.78
3.0
2.7
umol/l
4306.8
5819.0
0.40
517
4013
(3002582) Erythrocytes [#/volume] in Urine
674
5324
1.40
10.77
4.0
3.3
e6/l
26.9
76.4
3.12
519
4105
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
42
134
3.18
10.72
1.5
1.5
u/ml
16.9
24.2
—
7
26
(3016502) Oxygen saturation in Arterial blood
287
1919
1.58
10.69
8.5
8.0
%
95.7
95.5
0.22
281
1852
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
39
119
3.32
10.69
1.3
1.4
—
595.8
—
0
12
(3014576) Chloride [Moles/volume] in Serum or Plasma
337
2337
1.53
10.67
8.4
6.9
mmol/l
103.9
104.3
0.85
329
2285
(3000991) Gas panel - Venous blood
238
1526
1.63
10.55
9.3
8.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
362
2569
1.50
10.24
2.5
2.5
g/l
2.3
2.3
1.03
342
2380
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
403
2.18
10.18
1.3
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
267
1777
1.58
10.13
9.0
8.5
g/l
118.2
120.7
1.18
262
1715
(3017143) Hepatitis C virus Ab [Presence] in Serum
242
1577
1.61
10.03
1.7
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
248
1630
1.59
9.92
8.0
7.1
mmol/l
1.3
1.4
0.06
240
1567
(40768443) Skin Pathology biopsy report
137
766
1.85
9.89
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
384
2785
1.47
9.70
2.4
2.5
umol/l
11.8
12.8
2.17
366
2585
(3023183) Ammonium ion [Moles/volume] in Plasma
83
392
2.16
9.65
3.0
2.8
umol/l
35.7
35.6
0.02
74
329
(3022145) Colonoscopy Study observation
283
1936
1.54
9.48
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1891
17962
1.74
9.43
14.1
11.0
u/l
25.9
25.9
0.01
1831
17311
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
91
450
2.07
9.40
2.8
3.2
mg/l
1.5
1.6
0.75
85
410
(36660697) Celiac disease serology panel - Serum
194
1221
1.65
9.24
1.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
301
2100
1.51
9.19
2.2
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
342
2449
1.48
9.18
28.7
25.9
inr
1.4
1.4
0.06
36
327
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
254
1709
1.56
9.16
1.6
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1838
17376
1.59
8.80
18.2
14.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
145
856
1.75
8.75
4.6
3.9
mmol/l
24.2
24.1
0.20
133
771
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
298
2097
1.49
8.70
2.2
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1712
15959
1.46
8.65
6.6
6.1
mmol/mol
40.8
40.3
0.69
1595
14674
(3000570) Elastase.pancreatic [Mass/mass] in Stool
99
521
1.95
8.62
1.5
1.4
ug/g
273.6
280.5
0.15
63
304
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
454
3468
1.40
8.52
3.3
3.0
mmol/l
2.5
2.5
1.09
382
3057
(3002256) Pathology report gross observation
313
2234
1.47
8.51
1.4
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
373
2755
1.43
8.46
2.1
2.1
s
29.7
29.8
0.09
363
2661
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
334
2417
1.46
8.46
2.5
2.6
%
20.1
22.5
3.19
285
2064
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
485
3751
1.38
8.44
1.8
1.8
mg/l
1.2
1.3
0.16
386
2902
(3015171) Extractable nuclear Ab [Units/volume] in Serum
110
608
1.86
8.27
1.3
1.2
u/ml
2.4
0.9
0.41
15
54
(3026782) Osmolality of Urine
455
3496
1.39
8.21
3.2
2.8
mosm/kgh2o
545.0
542.5
0.07
380
2964
(3003327) Ova and parasites identified in Stool by Light microscopy
88
453
1.99
8.18
1.5
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
679
5556
1.33
8.16
2.7
3.1
ng/l
1537.2
1449.6
0.12
581
4765
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
314
2261
1.46
8.14
4.6
4.7
%
33.2
32.7
0.39
215
1481
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
179
1140
1.63
8.14
1.8
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
36
125
2.91
8.02
1.9
2.0
%
47.7
43.4
—
7
14
(3005719) IgG [Mass/volume] in Serum or Plasma
194
1266
1.59
7.98
2.9
2.7
g/l
11.0
10.6
0.55
177
1151
(3000850) Epithelial cells [#/volume] in Urine
481
3758
1.37
7.78
3.0
2.6
e6/l
4.5
5.4
1.20
417
3288
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1715
16069
1.43
7.71
18.8
14.4
ml/min/173m2
77.7
77.4
0.27
1460
13298
(3014765) Yersinia sp identified in Stool by Organism specific culture
93
500
1.90
7.64
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
38
141
2.73
7.52
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
166
1059
1.62
7.50
1.4
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
93
505
1.88
7.42
1.3
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
672
5549
1.31
7.42
2.8
2.5
u/l
58.8
57.7
0.20
625
5111
(3007461) Platelets [#/volume] in Blood
1926
18524
1.73
7.34
30.8
22.6
e9/l
248.4
248.3
0.02
1885
18026
(46235355) HIV 1 and 2 tests - Meaningful Use set
276
1980
1.46
7.27
1.8
1.6
—
—
—
0
0
(3019225) pH of Specimen
260
1845
1.47
7.24
4.2
4.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
67
327
2.08
7.24
8.0
5.4
iu/ml
137.3
800.8
—
10
46
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
157
997
1.62
7.24
9.5
10.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
38
145
2.65
7.14
1.9
2.1
e9/l
1.0
1.1
0.19
21
88
(3024731) MCV [Entitic volume]
1925
18528
1.71
7.09
30.7
22.5
fl
91.9
91.4
5.23
1903
18241
(3035941) MCH [Entitic mass]
1925
18528
1.71
7.09
30.6
22.5
pg
30.5
30.4
2.19
1903
18239
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
151
955
1.63
7.08
2.5
2.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1925
18530
1.71
7.06
30.8
22.6
e12/l
4.4
4.5
7.13
1878
17966
(3010813) Leukocytes [#/volume] in Blood
1925
18533
1.70
7.02
30.8
22.6
e9/l
6.9
6.7
0.79
1876
17974
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1056
9298
1.28
6.99
2.9
2.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1925
18535
1.70
6.99
30.9
22.7
g/l
132.7
134.5
5.69
1905
18247
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
211
1448
1.51
6.93
3.9
3.9
ng/l
87.1
91.8
0.37
182
1256
(3051651) Icteric interference index of Serum or Plasma
31
109
2.87
6.80
3.2
3.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
335
2522
1.39
6.72
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1356
12359
1.29
6.66
4.4
4.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
373
2863
1.37
6.65
1.4
1.3
iu/ml
37.7
37.9
0.01
109
931
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
295
2178
1.41
6.63
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
170
1124
1.56
6.62
2.7
3.2
e9/l
4.4
4.1
0.69
123
851
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
813
6961
1.28
6.62
3.8
3.9
ng/l
31.1
60.8
1.83
589
5043
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
230
1623
1.47
6.59
2.7
3.0
ng/l
247.7
207.4
0.57
210
1484
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
89
496
1.83
6.58
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1757
16631
1.41
6.56
5.2
4.8
mmol/l
6.0
6.0
0.02
1606
15037
(3027945) Reticulocytes/100 erythrocytes in Blood
285
2095
1.42
6.56
2.5
2.5
%
1.9
1.8
0.35
252
1858
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
105
618
1.74
6.47
3.1
3.1
u/ml
0.3
0.4
0.85
55
352
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
92
521
1.80
6.46
1.5
2.5
g/l
0.0
0.0
0.00
83
481
(4035726)
225
1589
1.47
6.42
1.5
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
279
2053
1.42
6.38
5.2
4.3
u/l
240.4
249.9
0.51
266
1935
(3009445) Proteinase 3 Ab [Units/volume] in Serum
118
722
1.67
6.31
1.9
1.5
u/ml
5.6
22.3
—
6
21
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
33
126
2.65
6.23
1.2
1.1
titre
145.0
133.2
—
6
22
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
95
550
1.76
6.21
1.5
2.5
g/l
0.1
0.0
0.53
86
508
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
134
853
1.61
6.15
1.6
1.8
g/l
1.4
1.6
1.12
119
744
(3008295) Osmolality of Serum or Plasma
44
194
2.30
6.14
1.3
1.3
mosm/kgh2o
281.7
276.0
0.69
38
147
(3028026) IgM [Mass/volume] in Serum or Plasma
153
1006
1.56
6.12
1.7
1.8
g/l
1.3
1.5
0.74
139
912
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
74
399
1.89
6.09
1.2
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
90
517
1.78
6.05
1.6
2.5
g/l
0.0
0.0
0.00
81
480
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
679
1.67
5.96
1.9
2.5
g/l
3.2
3.1
0.19
92
540
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
45
3.80
5.81
1.7
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
117
732
1.63
5.77
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1596
14971
1.31
5.66
24.2
16.6
%
39.0
39.4
0.95
1132
10130
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
230
1672
1.42
5.62
2.1
2.5
ug/l
11.7
6.9
0.61
200
1481
(3025130) Human papilloma virus identified in Specimen
33
133
2.51
5.62
1.6
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
165
1125
1.51
5.61
2.4
2.5
au/ml
25.4
24.2
—
6
49
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
677
1.64
5.54
1.9
2.5
g/l
10.2
10.2
0.06
92
581
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
67
3.16
5.47
1.2
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
24
83
2.91
5.46
7.0
6.4
u/ml
35.2
69.1
—
9
22
(3019060) Gas panel - Arterial blood
179
1249
1.47
5.44
5.6
5.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
43
3.74
5.37
1.5
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
724
1.61
5.31
1.8
2.5
g/l
3.8
3.8
0.05
91
529
(3036481) Cortisol [Moles/volume] in Serum or Plasma
218
1587
1.42
5.29
2.7
2.2
nmol/l
373.0
369.1
0.09
192
1450
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
725
1.61
5.28
1.8
2.5
g/l
7.4
7.5
0.14
93
550
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
725
1.61
5.28
1.8
2.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
217
1581
1.42
5.24
2.0
2.6
e9/l
74.0
70.1
0.67
158
1212
(3003338) MCHC [Mass/volume]
1482
13816
1.27
5.23
29.4
20.1
g/l
331.2
332.0
2.36
1469
13711
(40759836) Histone Ab [Presence] in Serum by Immunoblot
29
115
2.54
5.13
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
29
115
2.54
5.13
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
29
115
2.54
5.13
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
198
1426
1.43
5.10
2.8
2.8
ml/min/173m2
67.4
63.6
0.68
88
580
(3028707) Methadone [Presence] in Urine by Screen method
32
134
2.41
5.06
2.4
2.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
79
463
1.73
5.01
2.4
1.5
g/l
0.2
0.2
1.11
74
439
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
118
767
1.57
5.01
1.0
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
94
578
1.66
5.00
1.6
2.4
g/l
38.0
37.4
0.44
85
501
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
79
464
1.73
4.97
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
29
117
2.50
4.96
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
29
117
2.50
4.96
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
29
117
2.50
4.96
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
646
5534
1.25
4.87
3.9
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
130
870
1.53
4.85
1.8
1.7
—
—
—
0
0
(3015736) pH of Urine
748
6519
1.23
4.79
3.6
3.6
—
5.7
—
0
5
(3009508) Creatinine [Moles/volume] in Urine
658
5657
1.24
4.78
3.4
3.2
mmol/l
6.8
7.2
2.01
549
4726
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
82
493
1.69
4.76
2.4
2.4
g/l
3.7
3.6
0.19
76
467
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
99
627
1.61
4.70
1.6
2.7
g/l
0.5
1.2
1.71
86
550
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1785
17119
1.35
4.61
5.7
5.2
mmol/l
2.6
2.7
4.12
1650
15621
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
72
423
1.73
4.55
1.5
1.2
u/ml
15.1
3.5
0.47
12
49
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
73
431
1.72
4.54
1.3
1.2
u/ml
7.1
9.0
0.20
15
76
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
341
2729
1.30
4.48
1.3
1.2
u/ml
13.0
12.0
0.08
105
1029
(3021589) Normoblasts [#/volume] in Blood
847
7525
1.21
4.39
10.6
9.8
e9/l
0.0
0.0
0.29
673
6126
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1685
16059
1.29
4.36
4.4
4.1
mmol/l
1.3
1.3
0.13
1528
14520
(3012544) pH of Venous blood
232
1769
1.35
4.27
4.5
3.6
—
7.4
—
0
10
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
91
2.54
4.13
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
48
258
1.88
4.09
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
66
393
1.70
4.02
4.0
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
631
5485
1.22
3.99
3.5
3.3
mg/l
562.1
306.0
0.55
416
3429
(3009466) Valproate [Moles/volume] in Serum or Plasma
44
232
1.92
3.98
5.3
4.8
umol/l
353.8
359.9
0.11
37
199
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
102
678
1.53
3.98
1.7
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
113
2.32
3.85
2.0
2.1
%
15.4
13.4
0.34
14
45
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
109
741
1.50
3.84
1.9
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
45
243
1.87
3.80
2.6
2.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
58
339
1.73
3.79
1.3
1.2
u/ml
1.1
5.0
—
5
29
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
88
575
1.55
3.72
1.7
1.5
titre
218.0
242.7
—
5
22
(1175426) CD3 cells/100 lymphocytes in Blood
26
115
2.28
3.71
2.0
2.1
%
74.5
72.6
0.32
26
106
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
112
776
1.47
3.61
1.7
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
39
205
1.92
3.59
1.5
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
931
8462
1.18
3.51
4.0
3.9
estimate
0.0
0.0
1.08
116
1496
(3020682) Albumin/Creatinine [Ratio] in Urine
655
5776
1.20
3.48
4.0
4.0
mg/mmol
7.0
8.7
0.76
410
3591
(3034860) Kappa light chains.free [Mass/volume] in Serum
91
612
1.51
3.41
3.2
3.5
mg/l
43.9
65.9
1.00
78
502
(3016879) Cocaine [Presence] in Urine
46
260
1.79
3.40
2.0
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
107
2.26
3.39
2.2
2.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
91
613
1.51
3.38
3.2
3.5
mg/l
36.7
80.8
1.12
76
505
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
56
336
1.69
3.37
1.3
1.3
miu/ml
272.1
209.9
0.44
19
141
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
225
1.84
3.33
1.8
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
123
882
1.42
3.33
1.4
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
89
2.37
3.32
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
240
1.81
3.32
1.6
1.7
g/l
0.5
0.9
2.13
29
183
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
226
1.83
3.29
1.8
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
87
585
1.51
3.27
1.6
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
82
547
1.52
3.21
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
113
804
1.43
3.20
2.4
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
43
243
1.79
3.20
2.2
2.3
u/ml
4032.0
1145.1
0.31
43
234
(3005322) IgE [Units/volume] in Serum or Plasma
132
966
1.39
3.19
1.3
1.3
u/ml
272.1
204.7
0.46
123
881
(3002032) Base excess in Venous blood by calculation
217
1712
1.30
3.18
4.4
3.5
mmol/l
1.6
2.0
0.67
194
1376
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
279
2274
1.26
3.16
8.9
7.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1737
16756
1.25
3.15
5.0
4.7
mmol/l
4.6
4.6
2.40
1600
15377
(3026250) Tacrolimus [Mass/volume] in Blood
17
67
2.55
3.12
26.4
31.9
ug/l
7.2
7.0
0.11
12
58
(44816559) Phosphatidylethanol [Mass/volume] in Blood
47
275
1.73
3.11
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
77
511
1.53
3.09
2.2
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
916
8375
1.17
3.08
5.4
5.2
estimate
0.0
0.0
0.50
120
1542
(3004588) Protein electrophoresis panel - Serum or Plasma
169
1295
1.33
3.06
2.7
2.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
40
225
1.79
3.03
1.9
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
69
449
1.56
3.03
2.0
1.7
e6/l
24392.0
14137.7
0.68
52
320
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
23
106
2.18
3.03
5.0
2.9
%
31.3
39.2
—
9
36
(3020630) Protein [Mass/volume] in Serum or Plasma
197
1547
1.30
3.00
2.7
2.7
g/l
66.9
66.5
0.34
182
1404
(3000764) Benzodiazepines [Presence] in Urine
47
279
1.70
2.97
2.0
1.8
—
—
—
0
0
(3013512) EKG study
608
5391
1.18
2.95
4.0
4.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
47
280
1.69
2.94
2.0
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
40
228
1.77
2.92
1.9
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
47
281
1.69
2.90
2.0
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
192
1510
1.30
2.90
3.7
3.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
14
52
2.70
2.89
2.1
2.3
%
31.6
29.4
0.16
14
45
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
38
214
1.79
2.89
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
34
185
1.85
2.88
3.7
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
89
2.26
2.87
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1720
16613
1.23
2.84
5.0
4.6
mmol/l
1.5
1.5
0.23
1582
15135
(3041096) Erythrocytes [Presence] in Urine by Automated
379
4412
0.83
2.83
3.8
3.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
59
377
1.58
2.82
1.6
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
47
2.78
2.81
1.1
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
38
216
1.77
2.81
2.2
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
147
1119
1.34
2.80
1.2
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
20
411
0.48
2.80
3.8
3.1
mmol/l
7.5
7.5
0.02
20
400
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
231
1.75
2.80
1.9
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
907
8330
1.16
2.79
4.0
3.9
estimate
0.0
0.0
0.00
118
1530
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
30
159
1.90
2.76
1.3
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
16
66
2.44
2.71
3.9
1.5
umol/l
168.0
91.0
—
7
38
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
146
1.93
2.70
1.4
1.4
g/l
8.0
7.0
0.34
20
99
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
146
1.93
2.70
1.4
1.4
g/l
0.4
0.4
0.20
20
99
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
146
1.93
2.70
1.4
1.4
g/l
2.6
3.0
0.64
20
100
(3006245) CD3-CD19+ cells/100 cells in Blood
14
54
2.60
2.70
2.1
2.3
%
7.6
10.1
0.57
14
46
(1761482) Bacteria [#/volume] in Urine by Culture
26
482
0.53
2.67
5.4
4.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
32
3.14
2.64
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
72
489
1.49
2.64
1.6
1.6
iu/ml
2.0
12.3
0.40
15
99
(3037756) Immunofixation for Serum or Plasma
63
417
1.53
2.61
1.8
1.6
—
—
—
0
0
(4062490)
28
148
1.90
2.61
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
79
1116
0.70
2.59
1.4
1.4
—
—
—
0
0
(4198724)
11
38
2.91
2.58
2.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
45
276
1.64
2.56
1.5
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
128
1.96
2.55
1.2
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
23
435
0.52
2.54
3.4
3.0
mmol/l
1.5
1.5
0.26
23
422
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
33
186
1.79
2.53
3.4
3.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
13
50
2.61
2.53
2.2
2.4
nmol/l
123.2
128.5
0.10
13
44
(3049717) Cytology report of Urine Cyto stain
97
704
1.40
2.52
2.6
2.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
26
136
1.92
2.50
1.3
1.4
u/l
46.8
33.6
0.80
21
109
(3019150) Specific gravity of Urine by Refractometry
423
3686
1.19
2.48
4.5
4.3
kg/l
1.0
1.0
0.05
50
539
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
26
3.47
2.48
2.6
2.3
umol/l
18.2
18.7
—
9
26
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
82
2.21
2.47
4.1
2.0
umol/l
6.9
8.6
0.24
13
46
(3008152) Bicarbonate [Moles/volume] in Arterial blood
150
1171
1.30
2.43
9.1
7.2
mmol/l
24.6
24.5
0.06
144
1095
(3035637) Corticotropin [Mass/volume] in Plasma
35
204
1.73
2.41
1.4
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
100
1340
0.73
2.40
3.9
4.1
%
0.1
0.6
0.75
31
348
(40761536) Microorganisms panel - Urine sediment
108
1428
0.74
2.38
4.1
4.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
104
2.03
2.36
1.8
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
71
2.26
2.34
1.1
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
532
4748
1.16
2.32
1.8
1.7
mmol/l
1.4
1.4
0.88
474
3951
(3024522) Salmonella sp identified in Specimen by Organism specific culture
38
230
1.66
2.30
1.9
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
236
1960
1.23
2.30
3.8
4.1
ug/l
47.4
20.5
0.41
202
1610
(44790048)
34
200
1.71
2.28
2.1
1.5
—
—
—
0
0
(44790049)
34
200
1.71
2.28
2.1
1.5
—
—
—
0
0
(44806118)
34
200
1.71
2.28
2.1
1.5
—
—
—
0
0
(44790047)
34
200
1.71
2.28
2.1
1.5
—
—
—
0
0
(4024509)
32
185
1.74
2.28
1.9
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
254
1.63
2.28
1.1
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
118
1530
0.76
2.28
4.2
3.8
mmol/l
1.2
1.2
0.01
106
1334
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
615
5557
1.15
2.26
4.9
5.0
ug/l
3.9
2.8
0.33
558
4973
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
50
326
1.55
2.25
1.3
1.2
u/ml
65.8
51.0
0.33
12
37
(3002385) Erythrocyte distribution width [Ratio]
1435
13731
1.15
2.25
26.3
18.8
%
13.9
13.8
3.69
1409
13404
(3021440) Promyelocytes/100 leukocytes in Blood
108
1415
0.75
2.25
3.9
4.0
%
0.2
0.1
0.20
39
408
(3009214) Lutropin [Units/volume] in Serum or Plasma
46
295
1.57
2.23
1.2
1.4
u/l
17.6
10.2
1.33
33
238
(3035320) C reactive protein [Mass/volume] in Body fluid
22
114
1.94
2.20
1.7
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
304
1.56
2.20
1.9
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
142
1118
1.29
2.18
2.5
2.2
nmol/l
12.4
12.7
0.16
118
990
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
136
1.85
2.18
2.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
35
212
1.66
2.13
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
62
429
1.46
2.13
2.9
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
104
1358
0.75
2.12
4.0
3.8
%
0.5
0.6
0.16
30
321
(3026692) Albumin [Mass/volume] in Peritoneal fluid
13
55
2.37
2.12
1.0
1.5
g/l
12.3
13.3
—
6
42
(40760888) Immunoglobulin light chains.free panel - Serum
65
455
1.44
2.11
3.8
3.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
114
878
1.32
2.07
3.7
2.5
%
1.6
1.2
2.35
114
872
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
31
2.91
2.07
1.3
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
126
985
1.30
2.06
3.3
3.1
pmol/l
4.4
4.4
0.01
111
863
(3003181) Sodium [Moles/volume] in Urine
52
350
1.50
2.05
1.4
1.3
mmol/l
58.0
59.7
0.13
45
278
(3017817) Protein [Mass] in Urine collected for unspecified duration
30
177
1.71
2.02
2.4
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
208
1.65
2.01
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
14
63
2.23
2.01
1.1
1.3
g/l
40.4
37.2
—
8
34
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
69
494
1.41
1.99
1.6
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
144
1151
1.27
1.99
3.3
3.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
35
217
1.62
1.97
1.1
1.4
pmol/l
287.8
288.5
0.00
24
167
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
33
202
1.64
1.96
1.2
1.2
nmol/l
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
16
3.76
1.93
1.2
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
25
142
1.77
1.93
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
56
390
1.45
1.89
1.8
1.8
iu/l
3.4
4.5
0.48
13
120
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
22
3.19
1.88
2.0
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
144
1.75
1.85
1.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
11
46
2.40
1.85
1.6
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
385
1.44
1.82
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
127
1012
1.27
1.82
1.3
1.2
iu/ml
148.3
138.1
0.12
45
382
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
82
615
1.35
1.82
3.9
2.7
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
53
2.27
1.80
1.2
1.7
—
2024630.0
—
0
5
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
18
94
1.92
1.80
1.3
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
18
94
1.92
1.80
1.3
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
23
3.05
1.80
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
365
3227
1.16
1.79
2.9
3.0
ug/l
0.7
0.7
0.97
245
2159
(3020191) Ethanol [Moles/volume] in Serum or Plasma
21
116
1.82
1.78
2.2
1.4
promille
1.5
1.1
0.59
16
90
(3028308) Erythrocytes [#/volume] in Pleural fluid
31
192
1.62
1.78
1.5
1.3
e6/l
8073.2
121642.4
1.85
18
111
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
36
2.51
1.74
1.1
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
24
2.92
1.72
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
13
3.85
1.71
1.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.69
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
90
693
1.31
1.69
3.6
3.3
u/ml
2026.9
5948.7
0.43
80
593
(3019832) Treponema pallidum Ab [Presence] in Serum
90
693
1.31
1.69
1.7
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
19
3.16
1.66
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
97
1.86
1.66
1.7
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
11
49
2.25
1.63
1.2
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
166
1.63
1.61
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
271
1.49
1.59
1.6
1.4
u/ml
104.3
124.2
—
6
53
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
52
372
1.41
1.57
1.8
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
152
1.65
1.56
2.4
1.8
%
10.9
11.1
0.09
25
152
(4211845)
16
85
1.89
1.55
3.1
3.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
58
425
1.38
1.53
2.8
3.1
nmol/l
0.8
0.8
0.54
39
332
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
86
1.87
1.50
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
81
627
1.30
1.49
2.7
3.2
g/l
0.2
0.3
1.86
38
249
(3028433) Virus identified in Specimen by Culture
12
58
2.08
1.49
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
53
385
1.39
1.48
1.6
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
256
2239
1.16
1.47
1.5
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
38
2.37
1.45
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
46
327
1.42
1.45
1.7
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
302
1.43
1.45
1.5
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
15
80
1.88
1.44
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
80
1.88
1.44
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
80
1.88
1.44
1.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
240
0.54
1.44
2.3
2.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
33
220
1.51
1.44
1.5
1.3
e6/l
2835.4
1771.1
0.32
22
151
(3044007) Cell count panel - Peritoneal fluid
12
59
2.04
1.43
1.6
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
22
2.73
1.43
1.5
1.4
umol/l
40.3
45.0
—
6
22
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
22
2.73
1.43
1.0
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
123
1490
0.81
1.43
3.9
4.0
%
0.5
0.9
1.97
45
443
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
35
237
1.49
1.42
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
21
126
1.67
1.40
1.1
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
104
1.74
1.37
1.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
23
2.61
1.36
1.3
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
35
240
1.47
1.35
2.3
2.5
mg/l
56.8
23.7
—
6
62
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
105
1.72
1.33
1.4
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
61
1.97
1.32
1.8
1.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
41
0.00
1.31
0.0
1.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
41
0.00
1.31
0.0
2.3
—
7.7
—
0
22
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
43
309
1.40
1.30
1.5
1.4
—
15.1
—
0
7
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
18
2.78
1.28
1.2
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
60
457
1.32
1.28
1.6
2.1
mg/l
10.4
12.0
0.98
53
419
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
44
2.05
1.26
5.3
8.4
—
—
—
0
0
(4094501)
65
502
1.30
1.26
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
154
1.57
1.26
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
484
4460
1.11
1.25
4.4
4.3
%
21.8
21.4
0.17
209
2219
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
187
1.50
1.24
1.0
1.1
u/ml
1.3
4.9
2.49
15
88
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
56
425
1.33
1.23
2.4
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
45
330
1.37
1.23
1.5
1.6
mu/l
373.4
275.2
0.46
38
300
(21494890) Protein electrophoresis panel - 24 hour Urine
30
204
1.48
1.22
2.7
2.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
19
2.64
1.21
1.2
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
357
1.35
1.20
2.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
197
1.48
1.19
1.8
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
22
141
1.57
1.17
3.4
4.8
u/ml
73.9
39.9
—
7
43
(3006462) Nitrate [Presence] in Urine
14
79
1.78
1.17
3.4
4.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
50
2.00
1.16
1.1
1.1
—
—
—
0
0
(44813793)
17
102
1.67
1.16
1.1
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
20
2.50
1.15
1.2
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
20
2.50
1.15
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
12
65
1.85
1.13
1.6
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
54
414
1.31
1.12
2.5
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
51
1.97
1.11
1.7
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
26
177
1.47
1.08
1.3
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
177
1.47
1.08
1.5
1.2
u/l
51.0
54.2
0.15
18
127
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
287
1.37
1.07
1.8
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
18
113
1.60
1.05
2.7
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
393
1.31
1.04
1.3
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
46
1.96
1.03
1.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
22
2.28
1.03
1.4
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
26
179
1.46
1.03
1.6
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
68
1.77
1.00
1.5
2.2
e6/l
632.7
27449.3
—
6
42
(3008536) Aspergillus sp Ab [Presence] in Serum
7
35
2.00
1.00
2.9
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
41
309
1.33
0.98
2.6
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
23
2.18
0.98
1.0
1.0
mg/g
9.5
6.7
—
5
23
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
23
2.18
0.98
3.6
5.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
140
1.51
0.97
1.9
1.6
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
9
50
1.80
0.96
1.8
1.4
umol/l
1.7
2.0
—
9
44
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
108
1.58
0.96
1.8
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
50
390
1.29
0.95
1.4
1.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
9
51
1.77
0.94
1.3
1.1
pmol/l
331.4
278.3
—
9
36
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
158
1.46
0.93
1.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
158
1.46
0.93
1.9
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
158
1.46
0.93
1.9
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
1.5
2.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
52
1.73
0.92
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
34
252
1.36
0.92
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
90
755
1.20
0.91
2.3
2.0
ug/l
0.6
1.7
1.60
74
666
(3008898) HLA-B27 [Presence]
59
474
1.25
0.90
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
63
1.75
0.90
1.6
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
11
63
1.75
0.90
1.1
2.4
—
39874.3
—
0
12
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
245
1.35
0.89
1.9
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
79
1.65
0.88
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
103
1.56
0.87
1.4
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
186
1.40
0.87
3.7
3.5
%
58.8
55.4
0.32
18
125
(3020891) Body temperature
90
760
1.19
0.86
6.4
4.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
290
1.32
0.86
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
55
441
1.25
0.86
1.5
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
238
1.35
0.86
1.3
1.2
u/ml
1.6
4.1
0.99
13
72
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
80
1.63
0.84
1.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
50
398
1.26
0.84
1.3
1.3
iu/l
37.5
35.3
0.20
41
336
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
231
1.35
0.83
2.1
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
266
1.32
0.82
2.0
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
206
1.36
0.81
4.0
4.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
31
232
1.34
0.81
1.3
1.2
u/ml
2.2
6.2
1.93
15
99
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
89
1.58
0.81
4.1
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
98
840
1.18
0.81
3.0
3.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
407
0.76
0.79
5.9
4.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
33
1.82
0.79
1.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
98
1.53
0.78
1.4
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.1
—
47.2
—
0
9
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
107
1.50
0.76
1.8
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(4015189)
9
54
1.67
0.74
4.9
2.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
54
1.67
0.74
1.0
1.3
ug/l
8.0
9.3
—
9
54
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
54
1.67
0.74
1.3
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
38
1.84
0.73
1.3
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
26
193
1.35
0.73
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
176
1.37
0.72
2.1
1.9
u/l
4243.4
1915.2
—
7
68
(3023410) Appearance of Cerebral spinal fluid
22
159
1.39
0.72
1.1
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
92
1.53
0.72
1.6
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
50
407
1.23
0.72
2.3
2.2
g/l
121.4
129.9
1.34
26
302
(40768446) Kidney Pathology biopsy report
10
60
1.67
0.72
1.2
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
185
1.36
0.72
1.9
2.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
68
1.62
0.71
1.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
23
168
1.37
0.71
1.2
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
40
1.75
0.71
6.1
8.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
26
1.93
0.70
8.4
13.7
mmol/l
4.5
5.4
—
5
26
(40758292) HTLV I+II Ab panel - Serum
5
26
1.93
0.70
1.2
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
41
1.71
0.70
2.1
2.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
27
204
1.33
0.69
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
213
1.32
0.68
1.1
1.1
u/ml
0.5
1.8
—
8
85
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
42
1.67
0.68
1.1
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
179
1.34
0.67
1.6
1.4
e6/l
18242.3
114092.7
1.04
18
125
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
43
1.63
0.67
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
69
586
1.18
0.66
1.1
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
28
1.79
0.66
1.4
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
86
1.51
0.66
1.1
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
111
1.44
0.66
1.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
197
1.32
0.66
1.1
1.0
u/ml
2.9
2.0
—
6
72
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
180
1.34
0.65
1.0
1.1
u/ml
0.5
1.5
0.79
11
71
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
55
459
1.20
0.64
1.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
112
1.43
0.63
1.2
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
85
739
1.16
0.63
1.8
1.9
u/l
41.0
38.8
0.48
76
646
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
37
297
1.25
0.62
1.4
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
30
1.67
0.61
7.6
8.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
50
1.60
0.61
2.3
1.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
21
156
1.35
0.61
2.0
2.0
—
1.1
—
0
5
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
51
1.57
0.60
1.6
2.0
ug/l
1.8
1.1
—
8
46
(3001729) Color of Synovial fluid
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
122
1.40
0.60
1.2
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
272
1.25
0.59
1.1
1.2
u/ml
237.9
274.7
0.32
21
155
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
327
1.23
0.58
1.7
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
22
166
1.33
0.58
3.8
3.1
mg/l
11.0
30.5
1.24
15
129
(3038177) Helicobacter pylori Ab [Presence] in Serum
28
219
1.28
0.58
1.2
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
53
1.51
0.58
3.6
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
53
1.51
0.58
3.6
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
140
1.36
0.58
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
184
1690
1.10
0.57
1.8
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
38
310
1.23
0.57
1.3
1.2
u/l
53.6
38.2
0.30
32
268
(3017569) Oxygen content in Arterial blood
5
86
0.58
0.56
3.0
2.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
185
1.30
0.56
2.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
68
782
0.87
0.54
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
37
304
1.22
0.53
1.9
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
91
1.43
0.53
1.1
1.3
nmol/l
139.3
143.9
0.15
13
91
(3001019) Free T4 and TSH panel - Serum or Plasma
55
640
0.86
0.52
1.6
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
40
1.50
0.51
1.8
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
26
206
1.27
0.51
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
144
1.32
0.50
2.2
2.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
65
1.39
0.50
1.4
2.0
ug/l
34.1
146.8
—
9
54
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
128
1164
1.11
0.50
3.2
3.7
kpa
5.2
5.2
0.29
117
1081
(3035933) Granulocytes/100 leukocytes in Blood
6
41
1.46
0.50
1.0
1.3
—
—
—
0
0
(4133840)
6
41
1.46
0.50
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
84
1.43
0.49
1.2
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
84
1.43
0.49
1.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
84
1.43
0.49
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
298
1.21
0.49
1.5
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
953
0.89
0.49
3.7
3.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
110
1.37
0.48
2.6
1.6
u/l
1.3
7.2
—
10
58
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
409
3903
1.06
0.48
1.6
1.7
pmol/l
467.2
31258258.3
3.24
339
3196
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
76
1.45
0.48
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
619
6408
0.95
0.48
4.2
4.1
—
—
—
0
0
(3009343) pH of Capillary blood
126
1151
1.10
0.46
3.2
3.7
ph
7.4
7.4
—
10
150
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
191
1.26
0.46
3.0
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
1.4
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
396
0.83
0.45
3.8
3.7
mg/l
26.0
26.0
0.00
19
256
(4268621)
20
156
1.28
0.45
2.7
2.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
50
1.40
0.45
1.6
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
21
165
1.28
0.45
1.1
1.1
u/ml
0.3
2.5
—
5
40
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
75
841
0.89
0.44
3.9
3.7
%
52.7
48.1
0.98
75
830
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
247
1.22
0.44
2.5
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
51
1.37
0.44
1.1
1.1
—
—
—
0
0
(4281824)
16
208
0.77
0.44
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
257
1.21
0.43
2.6
2.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
371
0.83
0.42
1.4
1.8
nmol/l
0.8
0.8
0.00
25
306
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
276
1.20
0.42
2.2
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
16
122
1.31
0.42
2.1
2.1
ug/l
4.0
1.9
0.70
16
106
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
26
212
1.23
0.42
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
114
1.32
0.40
1.2
1.2
mmol/l
11.8
11.8
—
9
39
(3002523) Influenza virus A Ag [Presence] in Specimen
24
195
1.23
0.40
1.2
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
16.3
—
0
18
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
346
0.84
0.39
5.0
3.6
%
59.0
58.2
0.12
29
346
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
2.6
2.0
mg/l
10.1
8.5
—
5
29
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
106
1.32
0.39
1.2
1.5
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
19
0.00
0.39
0.0
1.7
—
0.4
—
0
12
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.1
—
24.5
—
0
12
(1617658) Protocol used for examination of sentinel lymph nodes
12
159
0.75
0.38
1.1
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
41
472
0.87
0.37
3.3
3.2
mmol/l
25.0
25.1
0.02
32
412
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
333
0.84
0.37
4.9
3.2
e9/l
4.7
4.3
0.31
28
333
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
69
1.31
0.37
1.1
1.2
iu/ml
129.0
230.3
—
9
69
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.1
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
90
1.34
0.35
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
85
931
0.91
0.35
2.8
2.7
e6/l
0.3
0.4
0.03
80
906
(3040151) Glucose [Moles/volume] in Capillary blood
16
201
0.79
0.35
2.8
6.4
mmol/l
7.6
7.4
—
10
172
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
36
415
0.87
0.34
5.6
4.9
mmol/l
2.8
2.7
0.12
22
292
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
45
1.33
0.33
3.0
2.5
%
199.0
171.5
—
6
40
(3042733) HLA Ab [Presence] in Serum
6
46
1.31
0.33
1.8
5.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
183
1.20
0.31
1.7
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
273
0.84
0.31
1.2
1.1
iu/ml
54.9
73.6
—
9
60
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
53
1.32
0.30
1.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
53
1.32
0.30
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
7
98
0.71
0.30
1.1
1.3
—
1.4
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
229
0.83
0.30
1.7
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
55
1.27
0.30
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
55
1.27
0.30
1.4
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
12
93
1.29
0.30
2.3
1.7
u/field
0.5
2.6
—
6
71
(40768806) Pleura Pathology biopsy report
23
194
1.19
0.29
1.5
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
130
0.77
0.29
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
112
1198
0.93
0.29
1.8
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
85
1.30
0.28
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
518
1.10
0.27
1.5
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
140
1.22
0.27
1.1
1.0
u/ml
1.2
3.2
—
6
52
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
118
1108
1.07
0.27
3.1
3.7
mmol/l
1.6
1.9
0.40
95
834
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
35
394
0.89
0.26
2.6
3.4
u/ml
116.1
1007.8
0.77
35
370
(40767503) Oxygen content in Capillary blood by calculation
35
394
0.89
0.26
2.9
2.6
%
15.5
16.2
0.34
14
203
(3021901) Oxygen saturation in Capillary blood
30
341
0.88
0.25
2.8
2.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
404
0.89
0.25
1.5
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
34
302
1.13
0.24
3.4
3.5
%
1.5
1.5
0.03
28
239
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
77
1.17
0.24
3.1
3.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
81
0.74
0.24
1.7
1.2
—
—
—
0
0
(4034850)
63
583
1.08
0.22
15.3
10.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
41
1.22
0.22
1.2
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
14.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
4.2
—
0
10
(3036525) Urea [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
2.5
—
0
10
(3020491) Glucose [Moles/volume] in Blood
16
135
1.19
0.21
2.4
2.1
mmol/l
8.9
7.1
—
9
82
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
17.6
—
0
7
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
45.0
—
0
7
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.2
—
0
6
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3020650) Glucose [Presence] in Urine
6
48
1.25
0.20
1.3
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
334
0.90
0.20
2.8
3.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
136
1.18
0.20
1.2
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
108
1.21
0.20
1.2
1.1
mg/l
270.6
282.7
0.12
13
95
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
81
1.24
0.18
8.7
13.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
6
53
1.13
0.18
7.3
7.6
%
70.5
71.6
—
6
44
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
59
1.19
0.18
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
174
0.86
0.17
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
104
991
1.05
0.17
1.3
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
61
1.15
0.17
2.9
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
18
157
1.15
0.17
1.4
1.3
u/l
427.0
363.3
0.19
18
151
(3037556) Urate [Mass/volume] in Serum or Plasma
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
71
1.13
0.16
1.4
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
168
1.13
0.15
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
140
0.86
0.15
3.1
1.6
—
—
—
0
0
(4027681)
9
83
1.08
0.14
1.1
1.1
—
—
—
0
0
(4146454)
24
217
1.11
0.14
2.8
2.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
96
0.83
0.13
2.9
2.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
180
0.89
0.13
1.4
2.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
44
413
1.07
0.13
2.5
3.1
kpa
7.9
8.0
0.17
37
378
(3050129) First trimester maternal screen panel - Serum or Plasma
9
110
0.82
0.13
1.9
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
171
1.11
0.12
1.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
353
3591
0.98
0.12
5.9
4.5
—
—
—
0
0
(4306422)
21
230
0.91
0.11
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
126
0.87
0.11
1.5
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
182
1.10
0.11
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
221
1.09
0.11
1.8
1.6
%
60.2
61.6
0.07
18
144
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
115
0.87
0.10
3.0
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
19
173
1.10
0.10
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
449
4544
0.98
0.09
4.6
4.2
estimate
0.0
0.0
1.08
115
1490
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
360
0.94
0.09
1.1
1.4
e6/l
1328.0
999.2
0.10
26
290
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
360
0.94
0.09
1.1
1.4
e6/l
73.0
35.2
0.23
26
274
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
62
0.81
0.08
1.4
1.1
miu/ml
1124.2
1674.5
—
5
62
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
561
0.96
0.08
1.6
1.7
mg/l
3.1
3.9
0.24
41
410
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
38
362
1.05
0.07
1.6
1.5
pmol/l
122.2
256.4
1.58
38
357
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
71
0.84
0.07
1.2
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
98
1.12
0.07
2.6
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
42
439
0.96
0.07
1.9
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
30
317
0.95
0.07
1.6
1.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
87
1.03
0.07
1.0
1.2
u/l
293.9
396.7
—
9
79
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
91
0.88
0.06
1.9
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
103
0.87
0.06
1.1
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
188
1902
0.99
0.04
4.1
3.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
91
1.10
0.04
2.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
91
1.10
0.04
2.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
91
1.10
0.04
2.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
91
1.10
0.04
2.6
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
11
101
1.09
0.04
1.5
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
269
1.04
0.04
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
131
1.07
0.03
1.1
1.1
u/ml
1.9
3.4
—
5
48
(3044290) Cell count panel - Cerebral spinal fluid
34
333
1.02
0.01
1.2
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
15
144
1.04
0.00
1.3
1.5
nmol/l
0.5
0.2
—
9
105
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
146
0.96
0.00
1.1
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
24
234
1.03
0.00
1.3
1.1
—
13.3
—
0
11
(40768793) Breast Pathology biopsy report
43
424
1.01
0.00
1.3
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
15
155
0.97
0.00
2.1
2.0
mg/l
6.8
4.4
0.39
15
149
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
99
1.01
0.00
3.0
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
99
1.01
0.00
3.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
101
0.99
0.00
1.4
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
15
149
1.01
0.00
2.1
2.0
u/field
2.3
2.1
—
6
59
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
96
1.04
0.00
1.3
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
96
1.04
0.00
1.3
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
46
456
1.01
0.00
2.2
2.3
ug/min
79.8
90.4
0.12
28
274
(3003694) ABO and Rh group [Type] in Blood
438
4384
1.00
0.00
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
97
1.03
0.00
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
97
1.03
0.00
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
97
1.03
0.00
2.6
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
227
1.01
0.00
1.2
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
5
51
0.98
0.00
2.2
1.4
%
40.8
23.8
—
5
34
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.1
—
1.4
—
0
21
(3015183) Erythrocyte sedimentation rate
6
69
0.87
0.00
1.5
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
81
0.99
0.00
1.3
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
98
0.92
0.00
6.7
6.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
82
0.98
0.00
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
75
0.93
0.00
3.1
1.7
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
36
360
1.00
0.00
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
9
92
0.98
0.00
1.0
1.7
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
74
0.95
0.00
3.1
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
85
0.94
0.00
1.4
1.1
u/l
30.0
24.2
—
8
63
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
85
0.94
0.00
1.4
1.1
u/l
76.9
77.4
—
8
67
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
2.1
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.5
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
84
0.95
0.00
1.3
1.5
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
5.0
—
395.4
—
0
8
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
74
0.95
0.00
3.1
1.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ORAL_LEUCOPLAC_RELAT and mortality.

Females

Parameter HR [95% CI] p-value
K11_ORAL_LEUCOPLAC_RELAT 1.15 [1.04, 1.27] 0.005
Birth year 0.994 [0.98, 1.0] 0.175

During the follow-up period (1.1.1998 — 31.12.2019), 1192 out of 5953 females with K11_ORAL_LEUCOPLAC_RELAT died.

Males

Parameter HR [95% CI] p-value
K11_ORAL_LEUCOPLAC_RELAT 1.278 [1.15, 1.42] < 0.001
Birth year 0.994 [0.98, 1.0] 0.25

During the follow-up period (1.1.1998 — 31.12.2019), 1068 out of 4459 males with K11_ORAL_LEUCOPLAC_RELAT died.

Mortality risk

Mortality risk for people of age

years, who have K11_ORAL_LEUCOPLAC_RELAT.

N-year risk Females Males
1 0.089% 0.354%
5 0.599% 1.888%
10 1.725% 4.593%
15 3.232% 8.523%
20 5.64% 14.425%

Relationships between endpoints

↥

Index endpoint: K11_ORAL_LEUCOPLAC_RELAT – Oral leukoplakia and related diseases

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data